Medindia

X

The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports

Tuesday, August 31, 2010 Corporate News J E 4
Advertisement
DALLAS, Texas, August 31, 2010 ReportsandReportsannounces it will carry the The Top 10 Cardiovascular Device Companies:Market trends, growth strategies, and SWOT analyses Market Research Report inits store.

Browse the complete Report on:http://www.reportsandreports.com/market-reports/the-top-10-cardiovascular-device-companies-market-trends-growth/

Search More Then 45000 Market Research Reports at ReportsandReports(http://www.reportsandreports.com/)

The cardiovascular (CV) device industry is highly competitive and hasreached maturity resulting in single digit growth rates of prominent devicessuch as pacemakers, defibrillators, and drug eluting stents (DES).Innovations in niche sectors such as atrial fibrillation (AF) and ventricularassist devices (VADs) are poised for double digit growth in the near tomid-term future. From 2007-09, the top three companies in the CV segmentacquired other smaller firms to expand their product portfolios and to gainmarket share in new geographies. Some major companies also establishedmanufacturing facilities outside the US to enhance cost containment andproduct distribution. The CV device market remained relatively resilientduring the economic downturn compared with other healthcare (http://www.reportsandreports.com/market-research/healthcare/) segments. The2007-09 period also witnessed a considerable rise in consolidation activitiesamong major companies.

This report provides detailed profiles of the top 10 cardiovascular (CV)device companies and brief profiles of other major players. It alsoelucidates trends within the cardiovascular device market. The detailedprofiles contain descriptions of business, financial performance, growthstrategies and SWOT analyses.

The CV device industry is highly regulated around the world withstringent guidelines defined by regulatory bodies. The medical deviceapprovals by governing bodies such as the FDA in the US have become verymeticulous that CV device manufacturers are launching products outside the USsuch as Europe and Canada. Since the prices are strictly regulated outsidethe US, manufacturers will be forced to launch their products in the US for asimilar price. In the long run, the pricing pressures would continue toprevail and limit the profitability margins for CV device manufacturers.

Significance of CV device innovation

Markets reaching saturation for major revenue generators in the CV devicesegment such as ICD, pacemaker and DES. New device innovation will be theonly parameter that will assure a company of its competitive edge. Noveltechnologies that are uncontested would help a company by allowing it tocharge premium pricing. Research & development (R&D) initiatives andinterdisciplinary knowledge will remain the benchmark for assuring acompany's success and commanding prevalence in the market.

Decline in capital expenditure of hospitals

In the US, hospitals spend a considerable amount of their revenues oncapital expenditure to improve their facilities and purchase new medicaltechnology. However, the impact of economic recession since 2008 had forcedhospitals to decrease their capital expenditure by almost 6%. This declinewill impact the medical devices industry across all sectors in the CV devicedivision. Some segments of the CV device industry such as ICD, pacemakers,heart valves and stents will remain insulated from the economic impact giventheir non-elective nature of associated procedures. other low budget,high-frequency CV accessories that hospitals purchases on a regular basiswill be affected due to decline of capital expenditures.

Read Full TOC of Report :http://www.reportsandreports.com/market-reports/the-top-10-cardiovascular-device-companies-market-trends-growth/

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depthmarket research studies of over 5000 micro markets, and 25 industry specificwebsites. Our client list boasts almost all well-known publishers of suchreports across the globe. We as a third-party reseller of market researchreports employ a number of marketing tools, such as press releases,email-marketing and effective search-engine optimization techniques to driverevenues for our clients. We also provide 24/7 online and offline supportservice to our customers.

(Due to the length of these URLs, it may be necessary to copy and pastethe hyperlinks into your Internet browser's URL address field. Remove thespace if one exists.)The analysis is based on: - Each company's consolidated and segmental financial performance; - Each company's growth strategies and major acquisitions and divestments relating to the CV devices market; - Key partnerships and alliances formed by these companies; - Business-related strengths and weaknesses of these companies and insights into the opportunities and threats facing them. Key features of this report Drivers - Innovations in CRM and DES segments such as MRI compatible pacemakers from Medtronic and Abbott's Xience drug eluting stent with their positive clinical outcomes support stronger evidence for long-term benefits. - Emerging markets for DES in Canada, China and parts of Asia furnish opportunities to expand businesses for CV companies. - Ageing population in industrialized markets such as the US, Europe and Japan are increasing. Moreover, the ICDs and pacemakers in these geographies are expected to have a second-phase of CRM implants. Resistors - The safety and efficacy of DES are under scrutiny following numerous clinical studies and more studies are being executed to justify the long-term efficacy of DES intervention. - Markets for ICDs and pacemakers have reached maturation. ICD sales are growing between 4-5% and pacemakers between 2-3% annually. - Reduction in reimbursement affects sales and profitability for CV device manufacturers. Scope of this report - Learn from the business operation strategies of the premier CV device companies to target future growth markets effectively, avoid their mistakes, and replicate their successes. - Benchmark your performance against the leading CV device companies. - Analyze the growth strategies of major players in the CV industry and how their business models are planned for the next 3 to 5 years. - Compare performances of the top 10 companies in the CV market with respect to acquisitions, new product innovation, geographic expansion, and industry challenges. - Save time, money and resources on analyzing the performance of leading CV device companies using this report. Key Market Issues Pricing pressures due to industry regulations

SOURCE MarketsandMarkets
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Naurex's Novel Antidepressant GLYX-13 Recognized a...
S
NIST-traceable Temperature Tracking Provides Visua...